Skip to main content

CTT Pharmaceutical Holdings, Inc.

CTTH
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001035422

In the last 90 days, CTT Pharmaceutical Holdings, Inc. insiders filed 11 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Holders of 5% or more of CTTH

Holders whose latest Schedule 13D or 13G filing reports 5% or more of CTT Pharmaceutical Holdings, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of CTT Pharmaceutical Holdings, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on CTT Pharmaceutical Holdings, Inc., newest first.

No Schedule 13D or 13G filings on CTT Pharmaceutical Holdings, Inc. are on file.

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell CTT Pharmaceutical Holdings, Inc. shares.

No Form 144 notices for CTT Pharmaceutical Holdings, Inc. are on file.